1. Public Health Response to Genital Herpes

2. Use of HSV-2 Serologies for Dx Dx of genital lesions/symptoms- yes performance of two step approach pcr vs.serologic testing for lesion resources to pay for serologic testing

3. Use of HSV-2 Serologies for Dx and Screening in STD Clinics Implementation training of staff impact on clinic flow screening pre and post test counseling serologic screening and therapy cost follow-up

4. HSV-2 Serologic Testing HIV Positive Time for symptom screen Strongly consider screening all HIV- positives Move HIV Treatment guidelines forward to include screening considerations and treatment recommendations

5. Screening in partnerships with HSV-2 discordance Yes, esp. with recent transmission data Where to offer screening Counseling and treatment guidelines fro prevention of transmission Recommendations for follow up

6. Screening General population-NO Universal screening in pregnancy- the debate continues Needs: Neonatal HSV as reportable disease Impact on c-section rates Feasibility outside of Seattle Impact of test performance in low prevalence areas